Blood immune analysis for precision diagnosis of medication allergy

Blood immune analysis for precision diagnosis of medication allergy - Immune monitoring of medication allergy

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON57077

Enrollment

400

Registered

2024-07-16

Start date

2025-09-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medication allergy Medication allergy

Interventions

nvt

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Aged 18 years or older - Have recently been diagnosed with a type I medication allergy - Provided written informed consent

Exclusion criteria

Exclusion criteria: under age 18

Design outcomes

Primary

Measure	Time frame
The main study parameter is the detection of allergen-specific IgE, either soluble in plasma or on the cell surface of immune cells. Allergic sensitization will be defined as detection of IgE concentrations above the 95th percentile of that detected in unaffected controls	—

Countries

Netherlands

Contacts

Public ContactM.C. Zelm

Erasmus MC, Universitair Medisch Centrum Rotterdam

m.vanzelm@erasmusmc.nl010-7043171

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jul 3, 2026